Guidelines on nicotine dose selection for in vivo research
2006 · Psychopharmacology · 821 citations
https://doi.org/10.1007/s00213-006-0441-0
R
Rachel F. Tyndale
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
580
Papers
25.6K
Citations
84
h-index
375
i10-index
Rachel F. Tyndale is an academic researcher from Centre for Addiction and Mental Health. The author has contributed to research in topics: Smoking Behavior and Cessation & Nicotinic Acetylcholine Receptors Study & Pharmacogenetics and Drug Metabolism. The author has an h-index of 84, co-authored 493 publications.
ORCID: 0000-0003-1297-2053Papers by this author
worksLarge-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
2017 · Nature Genetics · 774 citations
https://doi.org/10.1038/ng.3892
Nicotine metabolism defect reduces smoking
1998 · Nature · 435 citations
https://doi.org/10.1038/31623
Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians
2004 · Pharmacogenetics · 316 citations
https://doi.org/10.1097/00008571-200409000-00006
Rat Brain CYP2B-Enzymatic Activation of Chlorpyrifos to the Oxon Mediates Cholinergic Neurotoxicity
2012 · Toxicological Sciences · 60 citations
https://doi.org/10.1093/toxsci/kfs029
Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation
2012 · Carcinogenesis · 56 citations
https://doi.org/10.1093/carcin/bgs306
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat